Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Prescribing in Patients With Diabetes Mellitus With and Without Cardiovascular Disease. uri icon

authors

  • Gay, Hawkins C
  • Petito, Lucia C
  • Feinstein, Matthew J
  • Shah, Sanjiv J
  • Yancy, Clyde W
  • Kho, Abel N
  • Ahmad, Faraz S
  • Yu, Jingzhi
  • Persell, Stephen D
  • Jeffrey A. Linder, MD, MPH, FACP
  • Srivastava, Anand
  • Isakova, Tamara
  • Huffman, Mark D
  • Khan, Sadiya S
  • Mutharasan, R Kannan

publication date

  • January 1, 2022